| 0 (0%) | 04-26 10:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 13.32 |
1-year : | 14.22 |
| Resists | First : | 11.4 |
Second : | 12.18 |
| Pivot price | 10.72 |
|||
| Supports | First : | 10.14 |
Second : | 8.44 |
| MAs | MA(5) : | 10.64 |
MA(20) : | 10.72 |
| MA(100) : | 10.09  |
MA(250) : | 9.95 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 42.9 |
D(3) : | 48.3 |
| RSI | RSI(14): 39.7 |
|||
| 52-week | High : | 14 | Low : | 6.07 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ TIL ] has closed above bottom band by 17.3%. Bollinger Bands are 46.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 10.72 - 10.77 | 10.77 - 10.81 |
| Low: | 10.32 - 10.38 | 10.38 - 10.42 |
| Close: | 10.62 - 10.72 | 10.72 - 10.79 |
Tue, 02 Apr 2024
TLI investigator Dr. Denise Al Alam receives $1.5 million grant from CIRM to explore genetic defects of lung disease in ... - EurekAlert
Tue, 12 Mar 2024
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis ... - Nature.com
Mon, 12 Feb 2024
M&A rebound brings opportunities for transaction liability insurance - Insurance Business
Sun, 04 Feb 2024
Early Intervention is Critical to Saving Sight with Macular Degeneration - Newswise
Tue, 23 Jan 2024
Sands Point Risk launches MGA platform, unveiling expertise in TLI - Reinsurance News
Thu, 11 Jan 2024
Consider A Key Insurance Tool For Environmental M&A Deals - Law360
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 6.8 (%) |
| Held by Institutions | 65.9 (%) |
| Shares Short | 9 (K) |
| Shares Short P.Month | 13 (K) |
| EPS | -24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 34.72 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -14.1 % |
| Return on Equity (ttm) | -53 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -13.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -82 (M) |
| Levered Free Cash Flow | -82 (M) |
| PE Ratio | -0.44 |
| PEG Ratio | 0 |
| Price to Book value | 0.29 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|